Skip to main content

Table 5 Postoperative different treatments of early recurrent HCC patients according to different status

From: An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy

 

Alive (N = 9)

Dead (N = 20)

p-value

TACE

   

 No

1 (11.1%)

12 (60.0%)

0.020

 Yes

8 (88.9%)

8 (40.0%)

 

Targeted.therapy

   

 No

5 (55.6%)

8 (40.0%)

0.688

 Yes

4 (44.4%)

12 (60.0%)

 

Immunotherapy

   

 No

4 (44.4%)

8 (40.0%)

1.000

 Yes

5 (55.6%)

12 (60.0%)

 

Re.hepatectomy

   

 No

6 (66.7%)

19 (95.0%)

0.076

 Yes

3 (33.3%)

1 (5.0%)

 
  1. Abbreviations: HCC, Hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization; Re. hepatectomy, repeated hepatectomy